Derived from cannabidiol reduced neuropathic pain in preclinical tests and may open the way for new painkillers without psychoactive effects
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.